West African Resources and Battery Minerals can add profound upside to your portfolio. This is because the optimistic growth outlook for their profitability and returns make their high-growth potential appealing relative to their peers. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.
West African Resources Limited (ASX:WAF)
West African Resources Limited engages in the acquisition, exploration, and development of mineral resource projects in West Africa. Founded in 2006, and now run by Richard Hyde, the company now has 62 employees and with the market cap of AUD A$231.48M, it falls under the small-cap category.
WAF’s projected future profit growth is a robust 27.68%, with an underlying 59.27% growth from its cash flow from operations expected over the upcoming years. Profit growth, coupled with operating cash flow expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 23.98%. WAF’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Could this stock be your next pick? Check out its fundamental factors here.
Battery Minerals Limited (ASX:BAT)
Battery Minerals Limited engages in the exploration of mineral properties in Africa. The company was established in 2011 and with the stock’s market cap sitting at AUD A$37.77M, it comes under the small-cap category.
An outstanding 96.14% earnings growth is forecasted for BAT, driven by strong underlying sales growth over the next few years. It appears that BAT’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 26.42%. BAT’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Could this stock be your next pick? Have a browse through its key fundamentals here.
ResApp Health Limited (ASX:RAP)
ResApp Health Limited develops and commercializes the ResApp technology to provide health care solutions for respiratory disease. ResApp Health was established in 2014 and with the company’s market capitalisation at AUD A$51.41M, we can put it in the small-cap stocks category.